Home/Filings/4/0001104659-20-029269
4//SEC Filing

Limongelli John M 4

Accession 0001104659-20-029269

CIK 0001467652other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:23 PM ET

Size

7.0 KB

Accession

0001104659-20-029269

Insider Transaction Report

Form 4
Period: 2020-03-02
Limongelli John M
SVP & General Counsel
Transactions
  • Award

    Common Stock

    2020-03-02+100,000100,000 total
  • Award

    Stock Option (Right to Buy)

    2020-03-02+115,000115,000 total
    Exercise: $1.49Exp: 2030-03-02Common Stock (115,000 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021.
  • [F2]This stock option will vest in four equal, annual installments beginning on March 2, 2021.

Documents

1 file

Issuer

Neos Therapeutics, Inc.

CIK 0001467652

Entity typeother

Related Parties

1
  • filerCIK 0001445234

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:23 PM ET
Size
7.0 KB